Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04537715
Title A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Epizyme, Inc.

hematologic cancer

Advanced Solid Tumor


Itraconazole + Tazemetostat

Rifampin + Tazemetostat

Age Groups: senior | adult
Covered Countries USA | ESP

Additional content available in CKB BOOST